Bioventus Focused on Double-Digit Growth and Debt Reduction
The company's orthopedic sales grew 9% organically in 1Q22 as Bioventus targets double-digit organic growth for the full year....
The company's orthopedic sales grew 9% organically in 1Q22 as Bioventus targets double-digit organic growth for the full year....
The company grew more than 55% in 1Q22 on the strength of its narrow procedure focus and expanding direct sales...
Exactech is collaborating with JointMedica deliver the next generation of hip resurfacing to the global market....
The patent relates to the radiolucency of interbody structures and the ability to monitor progression towards an interbody fusion....
The company grew in the high single-digits during a better than expected 1Q22 and restated its full-year guidance for MACI....
The company grew in the low-teens for 1Q22 as procedures rebounded, but its ongoing business model transition incurred higher costs....
This clearance is in addition to the system’s already cleared use in anatomic shoulder arthroplasty....
The company will embark on the next phase of its evolution under the guidance of new CEO Dan Scavilla, who...
The company grew 25% in the first quarter of 2022 on the strength of its expanding portfolio, salesforce and surgeon...
The company grew in the low double digits for the first quarter of 2022 based on favorable order timing in...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.